SECsense Logo

Salarius Pharmaceuticals, Inc. 8-K Report: Key Updates on January 13, 2025

$SLRX
Form 8-K
Filed on: 2025-01-17
Source
Salarius Pharmaceuticals, Inc. 8-K Report: Key Updates on January 13, 2025

Here are the key pieces of information extracted from the provided section of the financial report:

  1. Entity Information:
  • Name: Salarius Pharmaceuticals, Inc.
  • CIK: 0001615219
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36812
  • Employer Identification Number (EIN): 46-5087339
  • Address: 2450 Holcombe Blvd, Suite X, Houston, TX 77021
  • Phone Number: 713-913-5608
  1. Filing Details:
  • Filing Type: 8-K (which is used to report major events that shareholders should know about)
  • Filing Date: January 13, 2025
  1. Stock Information:
  • Stock Type: Common Stock
  • Par Value: $0.0001
  • Ticker Symbol: SLRX
  1. Period Information:
  • Report Date: The report covers the date January 13, 2025.

Insights:

  • The filing is an 8-K, indicating that Salarius Pharmaceuticals is reporting a significant event or development on this date.
  • The company operates in the pharmaceutical sector, and the details around its stock may be relevant for investors looking to assess recent developments impacting its market performance.
  • The specific date of the report (January 13, 2025) suggests this is a forward-looking filing, possibly providing updates on corporate actions, financial performance, or strategic initiatives relevant to shareholders and the market.

This information can be vital for investors, analysts, and stakeholders monitoring the company's activities and making informed decisions.